# Twenty additional board concept groups, September 11

## Goal and authority

Owner asks to read GS-011 concept-review notes, then independently create,
editorially approve and implement 20 additional concept groups. Consult the
owner's live Google Sheet for candidate teaching points. Continue this GS-006
task; no archive, new thread, commit, push, install or deployment is authorized.
Agent editorial acceptance is distinct from named-clinician approval: all new
clinical records remain needs_clinician_review in the unapproved prototype.

## Starting state

Repository C:/Users/Kyle Kent/Projects/GamifySurgery; beta at 40638f6.
216 dirty paths at preflight, including unrelated graphics/movement/persistence
and all prior clinical batches. Preserve shared work; take scoped pre-edit copies.
Baseline 83 concept groups, 218 cases, 303 decision nodes; timing registry covers
106 test-bearing nodes and 357 test choices. Read AGENTS.md and GS-006 handoff.

## Scope and decisions

- Same count convention as previous batches: 20 stable scored concepts, four
  question variants each, in 40 two-node patients across ten families. Exactly
  80 questions. Most/all patients have an actual diagnostic gate between nodes.
- Use varied original clinical stories, first-person chief complaints, generated
  coherent identity/appearance, shuffled parallel options, descriptive anatomy,
  and explicit correct-answer explanations after mistakes. No generic adult stems.
- Match all test options, including distractors, to complete balance-owned game
  timing; non-test choices in mixed nodes say No test wait. Never key timings to
  correctness. Preserve existing gates, pending due ticks, FSRS and frozen saves.
- Care remains stable clinic evaluation, follow-up or referral planning, with
  honest external specialist testing. Do not pretend that hospital operations,
  acute stroke treatment or Level 3 procedures occur in current clinic rooms.
- GS-011-003/004: inspect and narrowly correct chart feedback so completed
  decision summaries do not repeat new findings, and wrong-answer feedback
  identifies the correct option. Do not broaden into close-button, economy,
  alerts, art or pathing work. GS-011-009 is an unconfirmed patient-shortage
  report; content expansion does not establish that its root cause is fixed.
- GS-011-007: verify the celiac serology concept's curriculum relevance; preserve
  existing content while documenting explicit versus inferred/supplemental scope.
- Board provenance requires exact public SCORE category/topic/depth/locator plus
  ABSITE/QE/CE relevance, separate from clinical evidence. Never claim exact exam
  frequency from the sheet or curriculum outline. Independently verify sheet facts.

## Live sheet grounding (read-only)

Gamify Surgery Concepts, spreadsheet 1PQLo5_dVWt73ZadSdWHpjJvLqamheavMRqQr3__wyyU,
Sheet1 (sheetId 0), modified September 11, read September 11. Read A1:H8,
A9:B220 (populated through row158), and relevant bounded detail ranges. Do not
copy the source sheet into tracked files or edit it. Candidate rows 56,82,110,
125,127,149,154,156 inform this batch; original vascular extension adds variety.
Row125 omits ACTH classification; row127 does not qualify surgery by risk.
These are source-review questions, not accepted clinical claims.

## Source-accepted roster, subject to final authored-content review

| Family | Two teaching points |
| --- | --- |
| Lactational breast abscess | Ultrasound evaluation; selected aspiration/drainage with breastfeeding preserved |
| Post-thyroidectomy voice change | Laryngeal examination; external superior laryngeal nerve/cricothyroid localization |
| Zenker diverticulum | Contrast swallow evaluation; false pouch above cricopharyngeus |
| Intermittent claudication / peripheral arterial disease | Resting ABI evaluation; structured exercise before invasive therapy in stable claudication |
| Asymptomatic PHPT | Skeletal DXA assessment; age under 50 as independent surgical indication |
| Confirmed endogenous Cushing syndrome | Plasma ACTH classification; adrenal imaging when ACTH suppressed |
| Pancreatic cyst | MRCP duct characterization; MCN recognition with appropriate limitations |
| Colon adenocarcinoma | Preoperative CT staging; oncologic segmental resection with regional nodes |
| Rectal cancer after neoadjuvant treatment | Multimodal response assessment; selected watch-and-wait with intensive surveillance |
| Symptomatic carotid stenosis after completed acute evaluation | Confirmatory vascular imaging; timely CEA assessment for suitable severe ipsilateral stenosis |

## Milestones and ownership

1. [x] Terra: read-only GS-011 and active bank/integration preflight.
2. [x] Source review and final roster: Sol owns four family sources and SCORE/
   celiac scope; Terra owns PHPT/Cushing/pancreas sources; Astra owns colorectal/
   carotid sources, live sheet and product decisions. Source briefs only.
3. [x] Delegate narrow chart-feedback implementation and tests; review actual diff.
4. [x] Delegate sequential clinical authoring milestones, one production writer
   at a time, with explicit family/helper ownership and source-approved briefs.
5. [x] Delegate admission, complete timing, service contracts, receipt and focused
   end-to-end domain tests. Astra reviews actual diffs, claims, keys and hashes.
6. [x] Full relevant suites, build/typechecks/boundaries and isolated browser
   checks; review screenshots, update GS-006/current handoffs and GS-011 status.

## Acceptance and validation

Exactly20 additive IDs,80 variants,40 routine-eligible cases; source/claim/review
integrity; no accidental duplicates or impossible demographic profiles. Every
new node is classified in timing registry. Test routes exist and results are
withheld until delivery. All40 encounters complete using reducer actions and
each correct pathway learns both concepts. Representative pending reload keeps
identity, shuffled choices, due tick and single result delivery. Wrong-answer
feedback explicitly names the intended answer without revealing it beforehand;
new findings appear in CURRENT UPDATE without duplication in decision summaries.

Run targeted regressions then full clinical, balance, domain and player suites,
full build with seven workspace typechecks and boundaries. Run heavy suites
sequentially to avoid the known all-cases 15-second concurrent-load timeout.
Browser tests use isolated Chrome storage at http://127.0.0.1:4173. Owner opens
START_GAME.cmd in the usual persistent profile; never touch that campaign.
Inspect scoped differences against pre-edit dirty copies, including untracked
whitespace. Retain ignored logs, not proprietary sources. Remind owner to say
"push to GitHub" at the validated local checkpoint.

## Next action

All 973 affected-package tests pass: clinical318, domain217, player427 and
balance11. Full build, all seven workspace typechecks, dependency and launcher
boundaries pass. The existing large-bundle advisory remains. Astra reviewed
scoped changes and final logs, independently verified all12 receipt source
hashes, and checked tracked/scoped new-file whitespace. The bank now contains
103 concepts,258 cases and383 nodes. Three isolated browser scenarios passed
individually (PAD, breast and rectal). Astra reviewed the final spec, logs and
all eight screenshots. Final evidence is in the review receipt. GS-006/current
handoffs and GS-011 statuses are updated. All requested work is complete; keep
this continuing task open and remind the owner to say "push to GitHub".

The browser spec required test-only fixture corrections for local access,
paused time, reopening the chart after acknowledgement, completed-details
selectors and the wrong-answer Enact Corrected Plan label. Sol identified the
last label mismatch from the failure evidence. No production changes resulted
from browser validation. Passing individual scenario logs supersede earlier
failed/terminated harness runs; only breast-specific code changed after the
other two passes. No long-term day-six shortage fix is claimed.

## Earlier implementation checkpoints

Full clinical initially found two uniquely-longest new answer labels and an old
case allowlist. Clinical review preserved specificity while shortening labels;
the receipt hashes were refreshed. Domain initially found two old allowlists.
All were corrected by appending the new batch without immutable exceptions or
changes to old clinical sources; final full suites pass as recorded above.

Current checkpoint: all20 groups are editorially accepted. Sol's fourteen-group
milestone passed five focused tests and clinical typecheck after clinical review
corrections; final labels were inspected. Terra is sole production writer for
integration, admission/timing/service contracts, source hashes and all40-case
domain checks. Sol is doing a read-only semantic timing audit. Before source
hashes, Terra will make the explicit PHPT ultrasound-label correction and clarify
two colon labels (contrast CT and resection of regional nodes). No prior batch
files or receipts may change. Full suites, build and browser acceptance follow.

Sol's read-only timing audit found no test incorrectly marked no_test. Astra
accepted dedicated new-batch profiles for overnight dexamethasone testing,
PET-CT, esophageal manometry, and aspiration with culture, plus a common CTA
estimate for carotid/runoff studies. PET/manometry use their existing service
contracts; CTA's fallback profile is not bound to carotid-only testing. Terra
will apply these before hashing; prior registry rows/profiles remain unchanged.

Browser acceptance should cover automatic admission, all initial-choice timing
labels, a pending-test save/reload with identical due tick/profile/appearance,
wrong-answer feedback identifying the key before corrective-forward testing,
completed feedback without duplicated new findings, and an honest combined
rectal-assessment service. Use PAD, breast and rectal cases in isolated Chrome
contexts at the canonical origin, with reviewed screenshots. Owner storage and
the existing server/launcher must not be reset or restarted.

Terra completed the narrow GS-011-003/004 chart-feedback milestone; Astra reviewed
the actual view-model diff and regression (16 focused tests and player typecheck
passed). Terra now authors the first six clinical groups and new dated helper.
Source review supports the accepted families. Astra rejected access-site
pseudoaneurysm for this batch because its SCORE relation was supplemental,
replacing it with stable claudication/PAD. Sol is checking that replacement's
precise scope and sources; Astra accepted the PAD addendum on September11.
Terra's first six groups/helper are now accepted after Astra reviewed actual
clinical text, helper construction, source limits and final validation logs
(five authoring tests and clinical-content typecheck). Astra also independently
reran the 16 chart-feedback regressions successfully. Sol is sole production
writer authoring the remaining14 groups. Terra completed a read-only integration
preflight: preserve prior hash-bound files/receipts and append all80 new exact
timing entries. New external contracts are needed for DXA, initial MRCP,
laryngoscopy, contrast swallow, ABI and combined rectal response assessment.
Generic existing ultrasound and CT services can serve explicitly named studies.

Final authoring review returned bounded corrections to Sol: remove stem/choice
category clues, attach timing to aspiration with culture, test Zenker wall layers,
give concrete carotid laterality/severity, establish PAD risk care and rectal
surveillance eligibility in every variant, and separate feeding precautions from
the abscess source-control claim. Use verified author initials instead of guessed
full names. Before freezing the receipt, make the PHPT localization distractor
explicitly name neck ultrasound so its declared ultrasound timing is unambiguous.

## Clinical authoring contract

New files belong under packages/clinical-content/src/development-batch/2026-09-11/.
Create a new dated helper; do not import or edit a hash-bound older batch helper.
Use content version development-batch.2026-09-11.1 and actual September11 review
dates. Export source/claim/question/case/review/service/timing data consistently.
The new helper should require explicit per-node timing classification and, for
test-bearing groups, explicit test/no-test choice references. Generate exact
case/node/question/choice ID-and-label registry entries from those authored
declarations, without lexical guessing or correctness inference. Integration
can append this new registry to the existing registry without rewriting old rows.

Sequential production ownership: Terra first authors the helper and three
endocrine/pancreas families (six groups,24 questions,12 cases), then Sol authors
the other seven families (14 groups,56 questions,28 cases) and a later bounded
integration milestone. Do not edit active release/balance until the family data
are reviewed. Existing services can be referenced; new services are explicit
external contracts to add at integration. Stage1 outpatient evaluation/referral
is appropriate where an external test is used; educational tier does not imply
onsite operative capacity. No exact real-world turnaround claim accompanies game
durations. Each next currentUpdate contains only newly returned findings, and
the question tests their consequence rather than repeating an intake fact.

The PHPT family uses age-appropriate DXA results and all profiles remain under50
for the age criterion. Cushing has unequivocally established endogenous disease
and suppressed ACTH, with alternative imaging choices made non-equivalent by the
question's target. Pancreatic MRCP patterns support the most likely cyst type,
not definitive histology. Preserve age/sex profiles that fit the clinical story.
